Market Cap 74.32B
Revenue (ttm) 17.49B
Net Income (ttm) 1.97B
EPS (ttm) N/A
PE Ratio 22.65
Forward PE 22.12
Profit Margin 11.25%
Debt to Equity Ratio 0.72
Volume 2,499,300
Avg Vol 3,143,468
Day's Range N/A - N/A
Shares Out 562.80M
Stochastic %K 74%
Beta 1.30
Analysts Strong Sell
Price Target $150.78

Company Profile

Emerson Electric Co., a technology and software company, provides various solutions in the Americas, Asia, the Middle East, Africa, and Europe. It operates through segments: Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, and Test & Measurement. It provides control, isolation, shutoff, pressure relief, and pressure safety valves, actuators, and regulators for process and hybrid industries. The company also offers intelligent instru...

Industry: Specialty Industrial Machinery
Sector: Industrials
Phone: (314) 553-2000
Address:
8027 Forsyth Blvd., Saint Louis, United States
StockAutoPro
StockAutoPro Sep. 8 at 3:14 PM
$EMR: Buy target $130.28 Sell target $138.89 Significant future growth potential observed in a major healthcare tech company based on recent strategic investments.
0 · Reply
StockAutoPro
StockAutoPro Sep. 7 at 4:29 PM
$EMR: Buy target $130.55 Sell target $139.18 Strong quarterly earnings report suggests potential growth in leading EMR sector company. Consider buying.
0 · Reply
StockAutoPro
StockAutoPro Sep. 4 at 3:08 PM
$EMR: Buy target $127.97 Sell target $136.47 Strong quarterly earnings suggest growth potential in leading EMR sector company. Consider for long-term investment.
0 · Reply
ZacksResearch
ZacksResearch Sep. 3 at 5:41 PM
$EMR up 30.2% over the past year — but is it all smooth sailing? 🚀 Despite strong gains, Emerson faces challenges in its Safety & Productivity, Discrete Automation, and Test & Measurement segments, with softness in specific international regions affecting growth. Opportunity or risk? Dive into the full analysis here 👉 https://www.zacks.com/stock/news/2746919/emerson-gains-from-business-strength-amid-persisting-headwinds?cid=sm-stocktwits-2-2746919-body-10794&ADID=SYND_STOCKTWITS_TWEET_2_2746919_BODY_10794
0 · Reply
ZacksResearch
ZacksResearch Sep. 3 at 4:41 PM
$EMR flexes strength in automation — but can it power through headwinds? Growth in Intelligent Devices and Software, plus the AspenTech buyout, are driving gains across key automation markets. Full bull/bear setup here 👉 https://www.zacks.com/stock/news/2746919/emerson-gains-from-business-strength-amid-persisting-headwinds?cid=sm-stocktwits-2-2746919-teaser-10780&ADID=SYND_STOCKTWITS_TWEET_2_2746919_TEASER_10780
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 2:12 PM
$EMR: Buy target $129.38 Sell target $137.95 Strong product pipeline suggests potential long-term growth in this leading EMR sector company.
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 3:44 AM
$EMR: Buy target $129.38 Sell target $137.95 Strong revenue growth suggests potential upside for this leading electronic medical record provider.
0 · Reply
Estimize
Estimize Sep. 1 at 2:00 PM
Wall St is expecting 1.61 EPS for $EMR Q4 [Reporting 11/11 BMO] http://www.estimize.com/intro/emr?chart=historical&metric_name=eps&utm_cont
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 25 at 10:47 AM
WATCHLIST AUG 25 2025. $GIB CGI Bags Multi-Year Contract to Replace Texas Comptroller's Legacy Accounting Systems With Modern CGI Advantage Enterprise Financial Platform $GPUS Hyperscale Data To Retain All Mined Bitcoin, Expand XRP Holdings And Build AI-Optimized Data Centers Through Sentinum Subsidiary $SMX SMX And Bio-Packaging Collaboration Delivers Physical-to-Digital Authentication For Packaging To Validate Recycling Loops And Strengthen Consumer Trust In Sustainability $TBPH Theravance Biopharma Completes Enrollment In Pivotal Phase 3 Trial For Blood Pressure Disorder, Advances Phase 3 CYPRESS Study Targeting Rare Neurodegenerative Disease Affecting MSA Patients $EMR Emera Appoints Jared Green as New Chief Financial Officer Effective December 15, 2025, Succeeding Greg Blunden
0 · Reply
NeuralNetworkSecurities
NeuralNetworkSecurities Aug. 23 at 1:25 PM
$EMR Emerson Electric Co is facing industrial automation demand cyclicality but portfolio transformation
0 · Reply
Latest News on EMR
Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 14 days ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR


Emerson Electric Can Greatly Benefit From Trade Agreements

Aug 13, 2025, 5:35 PM EDT - 4 weeks ago

Emerson Electric Can Greatly Benefit From Trade Agreements


Emerson Electric: High Risk To Growth (Rating Downgrade)

Aug 7, 2025, 2:51 PM EDT - 4 weeks ago

Emerson Electric: High Risk To Growth (Rating Downgrade)


Emerson Electric Co. (EMR) Q3 2025 Earnings Call Transcript

Aug 6, 2025, 9:26 AM EDT - 5 weeks ago

Emerson Electric Co. (EMR) Q3 2025 Earnings Call Transcript


Best Dividend Kings: July 2025

Jul 22, 2025, 9:31 AM EDT - 7 weeks ago

Best Dividend Kings: July 2025

ABBV ABM ABT ADM ADP AWR BDX


Emerson Releases 2024 Sustainability Report

Jul 1, 2025, 9:00 AM EDT - 2 months ago

Emerson Releases 2024 Sustainability Report


Emerson Electric: A Safe Buy For Long-Term Investors

Jun 30, 2025, 1:46 PM EDT - 2 months ago

Emerson Electric: A Safe Buy For Long-Term Investors


Best Dividend Kings: June 2025

Jun 24, 2025, 8:49 AM EDT - 2 months ago

Best Dividend Kings: June 2025

ABT ADM BDX BKH ED FTS FUL


Emerson Electric Set For Growth In The Second Half Of 2025

May 9, 2025, 6:28 PM EDT - 4 months ago

Emerson Electric Set For Growth In The Second Half Of 2025


Emerson Electric Co. (EMR) Q2 2025 Earnings Call Transcript

May 7, 2025, 9:35 AM EDT - 4 months ago

Emerson Electric Co. (EMR) Q2 2025 Earnings Call Transcript


Best Dividend Aristocrats For May 2025

Apr 29, 2025, 8:07 PM EDT - 4 months ago

Best Dividend Aristocrats For May 2025

ABBV ABT ADM ADP AFL ALB AMCR


Emerson Electric: Buy The Dip On This Dividend Aristocrat

Apr 23, 2025, 7:56 AM EDT - 5 months ago

Emerson Electric: Buy The Dip On This Dividend Aristocrat


3 Dividend Kings To Buy On Sale Now

Apr 17, 2025, 7:00 AM EDT - 5 months ago

3 Dividend Kings To Buy On Sale Now

BKH PEP


The Best Industrial Stocks to Buy

Apr 7, 2025, 8:51 PM EDT - 5 months ago

The Best Industrial Stocks to Buy

CSGS CSX DAL DLX FDX FLS HI


Albertsons Companies Set to Join S&P MidCap 400

Mar 4, 2025, 6:41 PM EST - 6 months ago

Albertsons Companies Set to Join S&P MidCap 400

ACI AZPN


Emerson Electric: Investors Should Be Patient

Feb 24, 2025, 12:31 AM EST - 7 months ago

Emerson Electric: Investors Should Be Patient


Elliott Statement on Aspen Technology, Inc.

Feb 19, 2025, 4:00 AM EST - 7 months ago

Elliott Statement on Aspen Technology, Inc.

AZPN


Emerson says $265 per-share bid for Aspen is 'best and final'

Feb 10, 2025, 1:52 PM EST - 7 months ago

Emerson says $265 per-share bid for Aspen is 'best and final'

AZPN


Emerson Issues Statement at Launch of AspenTech Tender Offer

Feb 10, 2025, 7:14 AM EST - 7 months ago

Emerson Issues Statement at Launch of AspenTech Tender Offer

AZPN


StockAutoPro
StockAutoPro Sep. 8 at 3:14 PM
$EMR: Buy target $130.28 Sell target $138.89 Significant future growth potential observed in a major healthcare tech company based on recent strategic investments.
0 · Reply
StockAutoPro
StockAutoPro Sep. 7 at 4:29 PM
$EMR: Buy target $130.55 Sell target $139.18 Strong quarterly earnings report suggests potential growth in leading EMR sector company. Consider buying.
0 · Reply
StockAutoPro
StockAutoPro Sep. 4 at 3:08 PM
$EMR: Buy target $127.97 Sell target $136.47 Strong quarterly earnings suggest growth potential in leading EMR sector company. Consider for long-term investment.
0 · Reply
ZacksResearch
ZacksResearch Sep. 3 at 5:41 PM
$EMR up 30.2% over the past year — but is it all smooth sailing? 🚀 Despite strong gains, Emerson faces challenges in its Safety & Productivity, Discrete Automation, and Test & Measurement segments, with softness in specific international regions affecting growth. Opportunity or risk? Dive into the full analysis here 👉 https://www.zacks.com/stock/news/2746919/emerson-gains-from-business-strength-amid-persisting-headwinds?cid=sm-stocktwits-2-2746919-body-10794&ADID=SYND_STOCKTWITS_TWEET_2_2746919_BODY_10794
0 · Reply
ZacksResearch
ZacksResearch Sep. 3 at 4:41 PM
$EMR flexes strength in automation — but can it power through headwinds? Growth in Intelligent Devices and Software, plus the AspenTech buyout, are driving gains across key automation markets. Full bull/bear setup here 👉 https://www.zacks.com/stock/news/2746919/emerson-gains-from-business-strength-amid-persisting-headwinds?cid=sm-stocktwits-2-2746919-teaser-10780&ADID=SYND_STOCKTWITS_TWEET_2_2746919_TEASER_10780
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 2:12 PM
$EMR: Buy target $129.38 Sell target $137.95 Strong product pipeline suggests potential long-term growth in this leading EMR sector company.
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 3:44 AM
$EMR: Buy target $129.38 Sell target $137.95 Strong revenue growth suggests potential upside for this leading electronic medical record provider.
0 · Reply
Estimize
Estimize Sep. 1 at 2:00 PM
Wall St is expecting 1.61 EPS for $EMR Q4 [Reporting 11/11 BMO] http://www.estimize.com/intro/emr?chart=historical&metric_name=eps&utm_cont
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 25 at 10:47 AM
WATCHLIST AUG 25 2025. $GIB CGI Bags Multi-Year Contract to Replace Texas Comptroller's Legacy Accounting Systems With Modern CGI Advantage Enterprise Financial Platform $GPUS Hyperscale Data To Retain All Mined Bitcoin, Expand XRP Holdings And Build AI-Optimized Data Centers Through Sentinum Subsidiary $SMX SMX And Bio-Packaging Collaboration Delivers Physical-to-Digital Authentication For Packaging To Validate Recycling Loops And Strengthen Consumer Trust In Sustainability $TBPH Theravance Biopharma Completes Enrollment In Pivotal Phase 3 Trial For Blood Pressure Disorder, Advances Phase 3 CYPRESS Study Targeting Rare Neurodegenerative Disease Affecting MSA Patients $EMR Emera Appoints Jared Green as New Chief Financial Officer Effective December 15, 2025, Succeeding Greg Blunden
0 · Reply
NeuralNetworkSecurities
NeuralNetworkSecurities Aug. 23 at 1:25 PM
$EMR Emerson Electric Co is facing industrial automation demand cyclicality but portfolio transformation
0 · Reply
scalpPilot
scalpPilot Aug. 22 at 2:39 AM
$EMR Industrial automation leader well positioned for long term factory modernization and reshoring trends portfolio transformation towards software and digital has improved growth profile
0 · Reply
JarvisFlow
JarvisFlow Aug. 15 at 3:54 PM
JP Morgan has adjusted their stance on Emerson Electric ( $EMR ), setting the rating to Neutral with a target price of 115 → 135.
0 · Reply
IN0V8
IN0V8 Aug. 8 at 5:45 PM
$EMR Buy Jefferies raises target price to $160 from $140
0 · Reply
IN0V8
IN0V8 Aug. 8 at 2:13 PM
$EMR Buy Jefferies raises target price to $160 from $140
0 · Reply
JarvisFlow
JarvisFlow Aug. 7 at 11:00 AM
Barclays updates rating for Emerson Electric ( $EMR ) to Equal-Weight, target set at 125 → 127.
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 5:15 PM
$EMR Q3 earnings beat — but what’s the real story? 🤔 Adjusted EPS at $1.52 topped estimates, yet net sales missed slightly at $4.55B. Despite this, the Software & Control segment drove a 4% YoY topline boost. 🚀 See the full analysis and future outlook here 👉 https://www.zacks.com/stock/news/2674031/emerson-q3-earnings-top-estimates-software-and-control-sales-rise?cid=sm-stocktwits-2-2674031-body-6446&ADID=SYND_STOCKTWITS_TWEET_2_2674031_BODY_6446
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 4:09 PM
$EMR beats on Q3 EPS — but the revenue miss and outlook shift raise flags Software & Control sales showed strength, yet overall revenues came up short and FY25 guidance got a reset. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2674031/emerson-q3-earnings-top-estimates-software-and-control-sales-rise?cid=sm-stocktwits-2-2674031-teaser-6381&ADID=SYND_STOCKTWITS_TWEET_2_2674031_TEASER_6381
0 · Reply
dipbuyer0326
dipbuyer0326 Aug. 6 at 3:42 PM
$EMR yikes this will never recover
0 · Reply
StockAutoPro
StockAutoPro Aug. 6 at 3:35 PM
$EMR: Buy target $123.67 Sell target $131.95 Despite recent challenges, this leading aerospace company shows strong recovery potential with new government contracts.
0 · Reply
_hedgehogx
_hedgehogx Aug. 6 at 12:30 PM
$EMR Testing $110 resistance after breakout. Bull flag formation suggests continuation to $120. Volume patterns confirm accumulation. Electrical sector strength supporting.
0 · Reply
mikesterz7
mikesterz7 Aug. 6 at 11:48 AM
$EMR 🚨 🚨 🚨 Revenue: $4.55 billion vs analyst estimates of $4.61 billion (3.9% year-on-year growth, 1.2% miss) Adjusted EPS: $1.52 vs analyst estimates of $1.51 (in line) Adjusted EBITDA: $1.23 billion vs analyst estimates of $1.30 billion (27.1% margin, 4.9% miss) Revenue Guidance for Q3 CY2025 is $4.90 billion at the midpoint, roughly in line with what analysts were expecting Management slightly raised its full-year Adjusted EPS guidance to $6 at the midpoint Operating Margin: 24.8%, up from 19.2% in the same quarter last year Free Cash Flow Margin: 21.5%, down from 22.8% in the same quarter last year Market Capitalization: $79.07 billion "Emerson's solid third quarter results reflect our sustained momentum, delivering strong underlying growth, profitability and cash flow, which we expect to continue as we finish the fiscal year," said Emerson President and Chief Executive Officer Lal Karsanbhai.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 6 at 11:32 AM
$EMR This release was subsequently corrected on the news feed to: Emerson reports Q3 adjusted EPS $1.52, consensus $1.51 -- Q3 revenue $4.553B, consensus $4.61B.
0 · Reply